Format
Sort by

Send to:

Choose Destination

Results: 4

Related Articles by Review for PubMed (Select 22401927)

1.

Can plasma DNA monitoring be employed in personalized chemotherapy for patients with advanced lung cancer?

Pan S, Xia W, Ding Q, Shu Y, Xu T, Geng Y, Lu Y, Chen D, Xu J, Wang F, Zhao C, Huang P, Huang P, Shen H, Hu Z, Lu S.

Biomed Pharmacother. 2012 Mar;66(2):131-7. doi: 10.1016/j.biopha.2011.11.022. Epub 2012 Feb 17.

PMID:
22401927
2.

Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.

Rosell R, Felip E.

Semin Oncol. 2001 Aug;28(4 Suppl 14):37-44. Review.

PMID:
11605182
3.

Personalized therapy.

Ujhazy P, Herbst R.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S401-3. doi: 10.1097/JTO.0b013e31826df27c. Review. No abstract available.

PMID:
23160334
4.

Systems mapping of genes controlling chemotherapeutic drug efficiency for cancer stem cells.

Wu W, Feng S, Wang Y, Wang N, Hao H, Wu R.

Drug Discov Today. 2014 Aug;19(8):1125-30. doi: 10.1016/j.drudis.2013.12.010. Epub 2014 Jan 4. Review.

PMID:
24397982
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk